 |
市場調查報告書
商品編碼
1671871
成癮治療市場：依類型、藥物類型、分銷管道和地區Addiction Treatment Market, By Type, By Drug Type, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025年全球成癮治療市場規模估計為 100.6億美元，預計到2032年將達到 149.4億美元，2025-2032年的年複合成長率為 5.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年市場規模 | 100.6億美元 |
| 歷史資料 | 從2020年到2024年 | 預測期 | 2025 至2032年 |
| 預測期：2025-2032年年複合成長率： | 5.80% | 2032年價值預測 | 149.4億美元 |
圖表.2025年成癮治療市場佔有率（依地區分類）
成癮是一種慢性健康狀況，影響著全世界數百萬人。它不僅對人們的身體造成影響，而且對人們的情感和經濟也造成影響。成癮很複雜，需要專門的治療方法來促進復原。成癮治療市場包括廣泛的服務，從排毒和康復到持續護理。神經科學的進步提高對成癮的認知並影響治療方法。治療方法擴大針對同時發生的疾病以及成癮的心理和社會方面。市場對基於證據的整體治療方案的需求日益成長。
市場動態：
全球成癮治療市場的發展受到物質濫用障礙盛行率不斷上升的推動，而這種障礙是由於人們容易獲得成癮物質而引起的。根據聯合國統計，全球約有2.71億人每年至少使用一次毒品。人們對有效治療方法的認知不斷提高，以及尋求幫助所帶來的恥辱感不斷減少，為行業相關人員創造了成長機會。然而，由於缺乏篩檢和治療基礎設施以及社會障礙，開發中國家的市場潛力仍未充分開發。高昂的治療費用也在一定程度上抑制了市場的成長。疫情期間，藥物輔助治療方法的接受度不斷提高，遠端醫療服務的擴展，可望使市場受益。
本研究的主要特點
- 本報告對全球成癮治療市場進行了詳細分析，並以2024年為基準年，提供預測期（2025-2032年）的市場規模和年複合成長率（CAGR%）。
- 強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
- 提供對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 全球成癮治療市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
- 主要企業包括 Teva Pharmaceutical Industries Ltd.、Pfizer, Inc.、Alkremes Plc.、Glenmark Pharmaceuticals、GSK plc.、Johnson &Johnson Services, Inc.、Novartis AG、Perrigo Company plc.、Cipla、Dr. Reddy's Laboratories Limited、Hikma、Temputical Bio、BioCorRx Inc. 和 Opiant Pharmaceuticals Inc.
- 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球成癮治療市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過用於分析全球成癮治療市場的各種策略矩陣來促進決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 限制因素
- 機會
- 影響分析
- 流行病學
- 市場趨勢
- 主要進展
- 監管情景
- 製造商收益
- 收購和合作場景
- 產品發布/核准
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章 全球成癮治療市場 - 冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
第5章 2020年至2032年全球成癮治療市場（依類型）
- 酒精成癮
- 煙草/尼古丁成癮
- 鴉片類藥物成癮
- 其他
第6章 2020年至2032年全球成癮治療市場（依藥物類型）
- 鴉片類藥物
- Buprenornhine
- 美沙酮
- 納曲酮
- 尼古丁替代療法
- 尼古丁口香糖
- 尼古丁貼片
- 尼古丁含片
- 尼古丁噴霧
- 非尼古丁藥物
- Varenicline
- 安非他酮
第7章 2020年至2032年全球成癮治療市場（依通路）
- 2025年及2032年市場佔有率分析（%）
- 與前一年同期比較成長分析
- 細分趨勢
- 醫院藥房
- 醫療用品商店
- 其他
第8章 2020年至2032年全球成癮治療市場（依地區）
- 2025年及2032年區域市場佔有率分析（%）
- 與前一年同期比較
- 區域趨勢
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
- 中東
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第9章 競爭格局
- 公司簡介
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Alkremes Plc.
- Glenmark Pharmaceuticals
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Dr. Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan NV
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
第10章 分析師建議
- 命運之輪
- 分析師觀點
- Coherent Opportunity Map
第11章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI4853
Global Addiction Treatment Market is estimated to be valued at USD 10.06 Bn in 2025 and is expected to reach USD 14.94 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 10.06 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.80% | 2032 Value Projection: | USD 14.94 Bn |
Figure. Addiction Treatment Market Share (%), By Region 2025
Addiction is a chronic health condition that affects millions globally. It impacts individuals physically as well as emotionally and economically. The complexity of addiction demands professional treatment approaches to facilitate recovery. The addiction treatment market encompasses a wide range of services from detoxification and rehabilitation to continuing care. Advancements in neuroscience have deepened the understanding of addiction and influenced treatment modalities. Therapies are becoming increasingly tailored to address co-occurring disorders as well as the psychological and social aspects of addiction. The market is witnessing rising demand for evidence-based and holistic treatment options.
Market Dynamics:
The global addiction treatment market is driven by the rising prevalence of substance abuse disorders fueled by easy access to addictive substances. According to the United Nations, around 271 million people globally use drugs at least once a year. Increasing awareness about effective treatment options and reduced stigma associated with seeking help are creating growth opportunities for industry players. However, the market potential remains relatively untapped in developing nations due to lack of screening and treatment infrastructure as well as social barriers. High treatment costs also restrain the market growth to some extent. The market is poised to gain from the growing acceptance of medication-assisted treatment approaches and expansion of telehealth offerings during the pandemic.
Key Features of the Study:
- This report provides an in-depth analysis of the global addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this includes Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Alkremes Plc., Glenmark Pharmaceuticals, GSK plc, Johnson & Johnson Services, Inc., Novartis AG, Perrigo Company plc., Cipla , Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., Eli Lilly and Company, Tempero Bio, BioCorRx Inc., and Opiant Pharmaceuticals Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global addiction treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global addiction treatment market
Detailed Segmentation-
- By Type:
- Alcohol Addiction
- Tobacco/Nicotine Addiction
- Opioid Addiction
- Others
- By Drug Type:
- Opioids
- Buprenorphine
- Methadone
- Naltrexone
- Nicotine Replacement Therapies
- Nicotine Gums
- Nicotine Patches
- Nicotine Lozenges
- Nicotine Spray
- Non-Nicotine Medication
- Varenicline
- Bupropion
- By Distribution Channel:
- Hospital Pharmacies
- Medical Stores
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Alkremes Plc.
- Glenmark Pharmaceuticals
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Epidemiology
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Addiction Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Addiction Treatment Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Alcohol Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tobbacco/Nicotine Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Opioid Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Addiction Treatment Market, By Drug Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Opioids
- Buprenorphine
- Methadone
- Naltrexone
- Nicotine Replacement Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nicotine Gums
- Nicotine Patches
- Nicotine Lozenges
- Nicotine Spray
- Non-Nicotine Medication
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Varenicline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bupropion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Addiction Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Addiction Treatment Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alkremes Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Dr. Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
